Synaptic dysfunction and septin protein family members in neurodegenerative diseases - Wikidata - awgldk - TriplyDB

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

http://www.wikidata.org/entity/Q27026829

about

Implications of GABAergic Neurotransmission in Alzheimer's Disease Septin Mutations in Human Cancers Copy number variability in Parkinson's disease: assembling the puzzle through a systems biology approach M30 Antagonizes Indoleamine 2,3-Dioxygenase Activation and Neurodegeneration Induced by Corticosterone in the Hippocampus FIJI Macro 3D ART VeSElecT: 3D Automated Reconstruction Tool for Vesicle Structures of Electron Tomograms Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?Proteome Analysis of Potential Synaptic Vesicle Cycle Biomarkers in the Cerebrospinal Fluid of Patients with Sporadic Creutzfeldt-Jakob Disease.Expression of sept3, sept5a and sept5b in the Developing and Adult Nervous System of the Zebrafish (Danio rerio).TAOK2 Kinase Mediates PSD95 Stability and Dendritic Spine Maturation through Septin7 Phosphorylation.Synaptic Adhesion Molecule Pcdh-γC5 Mediates Synaptic Dysfunction in Alzheimer's Disease.SORLA attenuates EphA4 signaling and amyloid β-induced neurodegeneration.SEPT14 Is Associated with a Reduced Risk for Parkinson's Disease and Expressed in Human Brain.Silica nanoparticles induce neurodegeneration-like changes in behavior, neuropathology, and affect synapse through MAPK activation.

P2860

Q26768593-43252E76-8DF5-4889-9111-0608C805ED62 Q28078227-6881D4AE-E964-42C5-BBD3-F2657F735D7C Q33364337-8E27FDA1-5AF1-4727-AC5F-D191E68C6B78 Q36199834-477EE838-F1E8-4108-AA81-D73F45492EAC Q36240275-7C81B679-6970-4311-9D83-AF428372FF89 Q38407177-E5B3F428-11A6-4274-92B6-2FF98C7AE6A7 Q38962792-5276AC0B-5A4E-429A-ACF7-A6AEF4B392A6 Q40607068-DAAAD0FC-5FEB-4721-A41E-F2C9C429E9C0 Q42320935-32F11170-AC1B-4847-8CC1-E7011BBF3820 Q45986630-A6DF17AE-ABCE-4305-90E5-E5564580B3E8 Q46129049-8A428C67-062B-4DC9-91D0-CD18DDC60A05 Q46167371-5AA757F8-B36C-43C8-8BC1-A6CFDB8C03CB Q48793033-AA1E75A0-2AA3-4EF3-AE11-67D8F3A8B5D5 Q55517771-F67E1D85-F5F7-4B7B-9ABF-42E84F79F398

P2860

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

http://www.wikidata.org/entity/Q27026829

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

@ast

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

@en

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

@nl

type

label

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

@ast

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

@en

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

@nl

prefLabel

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

@ast

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

@en

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

@nl

P1433

Q27026829-02FFAEAE-B663-40B3-A929-323AF1381BB7

P1476

Q27026829-1D645031-B8B2-4143-B20A-0E5BE9355F20

P2093

Q27026829-7BC770C8-9D74-4182-B02E-1D5753F9E85E

Q27026829-B33CF5FB-88BB-4538-B656-ABC467865D61

Q27026829-F7C8EB1A-3CFE-4041-863A-E11F44E3267A

P275

Q27026829-FD420A14-F64D-4A38-9615-DFE6B6B0CF5B

P2860

Q27026829-0422F941-8161-42D1-A643-5C7AEBCFD889

Q27026829-04592813-5987-4E73-B4D7-E46539CE783C

Q27026829-081838E6-9DED-4C21-85C1-43BAAABB5A9D

Q27026829-09DFBD21-AA31-4750-92B2-097953E4134A

Q27026829-0CB9CE63-BB27-4376-B4EE-C51C8F7C6BBE

Q27026829-10E35304-B2FE-43E8-B40E-5AE5E22404CB

Q27026829-138A1F0B-2535-4EC3-A555-116A59FCC0E1

Q27026829-1625E6F0-E25A-44AF-968D-8EC545C771C6

Q27026829-19E50843-5ABE-4401-9B01-AD270D4FC6EE

Q27026829-1CB3D601-589A-4F6B-B460-C3D6EC60C75A

P2888

Q27026829-513C0A6E-197E-4F61-BBCA-9F1FF710D046

P304

Q27026829-37A122EF-B60C-4BD1-A033-3FC8D8FDCB8E

P31

Q27026829-00564701-B3E4-4374-85AA-02140401A129

Q27026829-9841D494-DB31-4232-A667-325FEA57CD40

P3181

Q27026829-BE1E895F-9876-4EB9-A624-D05A8795EFDD

P356

Q27026829-373174F7-1741-4B71-A61F-382F1C274BCE

P407

Q27026829-62D1034D-03B7-43BA-8746-CC40AA05C6FD

P478

Q27026829-4EEB6B44-6C83-4477-94CC-C2C8A0427762

P50

Q27026829-449D7F78-C843-409B-9024-F3AC1514C569

Q27026829-A7F0746A-BE2F-4924-B91A-68739F94F8A5

P5008

Q27026829-A59D0DDA-3D3D-44C1-B698-454424D3869B

P577

Q27026829-ED1DBF79-422D-4D99-BD2D-54E5CD060743

P5875

Q27026829-C161C58C-64D9-4FBE-9BB1-41FDBA988014

P6179

Q27026829-B12B2DF4-3422-4027-A1F7-2BF995F07A23

P698

Q27026829-5C9C10E1-C43E-4C56-8D8F-AF4F716ACC70

P921

Q27026829-1A6799BA-DDCF-4AD7-AA71-C21EC428F78F

Q27026829-3A909A62-2746-4663-B298-71AA7200A0A6

Q27026829-5F8C0ADB-4847-4B0B-8249-7937E32273CD

Q27026829-9E241D0A-FFA3-45B6-BE09-F6BF00E2A48F

Q27026829-A80A6A6B-CD59-45D1-A990-DDF65D6B8AE5

Q27026829-C373DD0C-1529-44EF-BC1D-5DEA93060669

P932

Q27026829-8180AD5A-1C5A-4AD6-86A3-005C266ADF2F

P3181

P356

S13024-015-0013-Z

P1433

Molecular Neurodegeneration

P1476

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

@en

P2093

Kaisa MA Kurkinen

http://www.w3.org/2001/XMLSchema#string

Mikael Marttinen

http://www.w3.org/2001/XMLSchema#string

Mikko Hiltunen

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

The septin CDCrel-1 binds syntaxin and inhibits exocytosis

Parkinson's disease: from monogenic forms to genetic susceptibility factors

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Plasticity in the human central nervous system

Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool

Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

LRRK2 regulates synaptic vesicle endocytosis

P2888

s13024-015-0013-z

P304

16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2602974

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S13024-015-0013-Z

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Hilkka Soininen

Annakaisa Haapasalo

P5008

P577

2015-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274732815

http://www.w3.org/2001/XMLSchema#string

P6179

1038177599

http://www.w3.org/2001/XMLSchema#string

P698

25888325

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

transport protein

cytoskeletal proteins

physiological phenomena

P932

4391194

http://www.w3.org/2001/XMLSchema#string